title: [Peritonectomy and hyperthermic chemoperfusion in peritoneal carcinomatosis. Preliminary results].
abstract: BACKGROUND
  Peritoneal carcinomatosis can be actually treated by new surgical and oncological techniques. Aim of this work is to report preliminary results of a group of patients with peritoneal carcinomatosis, submitted to peritonectomy and intraperitoneal hypertermic chemoperfusion (IPHC).
  
  
  METHODS
  Age, sex, type of neoplasm, peritoneal carcinomatosis index (PCI), completeness of cytoreduction (CC), operative time, morbidity and mortality of patients submitted to IPHC have been considered.
  
  
  RESULTS
  From May 2001 to December 2004, 10 patients were submitted to peritonectomy and IPHC: 9 (90%) females and 1 (10%) male, aged from 49 to 72 years. Seven patients (70%) were affected of peritoneal carcinomatosis from ovarian tumor, three patients (30%) from colon cancer. The PCI was ranged from 8 to 25. The operative time was ranged from 6 to 14 hours. Two patients with a CC of 2 developed relaps and died respectively after 2 and 4 months. The remaining patients had a CC between 0 and 1. Of these last patients, 1 affected by ovarian cancer died 24 months after, 1 patient died 3 days after surgery for septic shock; the other patients are still alive with a period ranged from 1 to 30 months.
  
  
  CONCLUSIONS
  Our preliminary results suggest that the peritonectomy and IPHC can be effective only in patients with CC of 0 or 1, in the remaining cases these therapeutical methods should be avoided.
authors.affiliation: Department of Surgical Sciences, Organs Transplantation and Advanced Technologies, University of Catania.
authors.forename: I
authors.initials: I
authors.lastname: Di Carlo
authors.forename: M
authors.initials: M
authors.lastname: Sofia
authors.forename: G
authors.initials: G
authors.lastname: Scibilia
authors.forename: A
authors.initials: A
authors.lastname: Toro
authors.forename: P
authors.initials: P
authors.lastname: Scollo
mesh_terms: D000368:Aged; D002277:Carcinoma / Q000628:therapy*; D010478:Chemotherapy, Cancer, Regional Perfusion; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D008297:Male; D008875:Middle Aged; D010534:Peritoneal Neoplasms / Q000628:therapy*; D010537:Peritoneum / Q000601:surgery*